US high court lets stand attorneys' fee award to Takeda in Actos patent case
07 October 2009
Nancy Faigen
Please Login to read the full article.
07 October 2009
Nancy Faigen
nancy.faigen@informausa.com
The US Supreme Court has declined to hear Mylan Laboratories' and Alphapharm's appeal of a decision awarding Takeda $16.8 million in attorneys' fees, expenses and expert fees in connection with patent infringement litigation involving the antidiabetic Actos (pioglitazone).
On October 5th,...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: House adopts patent reform, but fee change could be trouble for Senate
- US Capitol Capsule: Senate & Supreme Court tackle issues of US patent system
- US Capitol Capsule: Obama expects more 'nickel and diming' of health reform
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
FEATURES
- Interview: Adimab's Gerngross seeks two sweethearts
- DKSH highlights one-stop benefits as it builds Asia market expansion services
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
